Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002255063 | SCV002526341 | uncertain significance | not provided | 2024-08-20 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002488635 | SCV002775473 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 42 | 2021-08-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002255063 | SCV003284199 | uncertain significance | not provided | 2022-10-18 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs760257421, gnomAD 0.08%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 434 of the ILDR1 protein (p.Pro434Leu). This variant has not been reported in the literature in individuals affected with ILDR1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1691657). |